Parameter Identifiability Under Limited Experimental Data in Age-Structured Models of the Cell Cycle Ruby E. Nixson, Helen M. Byrne, Joe M. Pitt-Francis, Philip K. Maini Abstract The mitotic cell cycle governs DNA replication and cell division. The effectiveness of radiotherapy and chemotherapy depends on cell-cycle position, with increased resistance during DNA replication and mitosis. Thus, accurate mathematical models of the cell cycle are essential for understanding and predicting treatment response. However, mathematical modellers often face the problem of a lack of publicly available, sufficiently resolved, time-series datasets for parametrising models. In this work, we consider how the ability to collate population summary measurements across the literature, from different cell lines and/or experimental set ups, affects identifiability of parameters for a cell cycle model. Initially synchronised cell populations gradually desynchronise over successive cycles, converging to balanced exponential growth (BEG) which is characterised by exponential population growth and steady, time-independent phase proportions. These proportions can be obtained from fluorescence-activated cell sorting (FACS) data. The increasing use of the Fluorescent Ubiquitination-based Cell Cycle Indicator (FUCCI) provides higher-resolution information on phase dynamics, such as minimum phase durations and variability. We present an age-structured PDE model in which cell-cycle phase progression follows a delayed gamma distribution. We derive analytical expressions for BEG phase proportions and other FUCCI-observable quantities, and use them to assess how data availability influences parameter identifiability. When parameters are not uniquely identifiable, we determine identifiable parameter groupings, thereby determining the minimum amount of data that must be available for successfully fitting structured population models of the cell cycle. keywords Cell cycle, mathematical modelling, structured PDE, age-structured models, FUCCI, FACS, data limitations † † equal-contributors: These authors contributed equally to this work. † † equal-contributors: These authors contributed equally to this work. † † equal-contributors: These authors contributed equally to this work. 1 Introduction The mitotic cell cycle governs the duplication of cellular content and division of a cell into two daughter cells. The cycle is comprised of four stages that must be completed sequentially before division can take place. Firstly, a cell enters the G_{1} phase, in which the cell size grows and preparation for DNA replication begins. Within this phase, a cell faces a “choice” to either remain in an actively cycling state, or to pause cell cycle progression in a reversible manner, known as quiescence or the G_{0} phase ( 27 ) . DNA replication takes place in the second phase, S , before progression into the G_{2} phase, in which preparation for division occurs, as well as repair of any damage accrued during the S phase. Following this, the cell enters mitosis, M , a short phase culminating in cell division. One common treatment for cancer is radiotherapy, and experimental results show that response to radiotherapy can be affected by cell cycle phase ( 37 ; 25 ; 31 ) . Cells in the M phase are most radio-sensitive, whilst cells in the S phase are most radio-resistant ( 54 ) . Quiescent cells are also radio-resistant ( 25 ) . Furthermore, chemotherapies for cancerous cells are also known to interact with the cell cycle, with some chemotherapeutic drugs modulating progress through the cell cycle, and others inducing a cell cycle phase-dependent response ( 41 ; 47 ; 35 ) . Therefore, accurate mathematical models of the cell cycle are essential when applying them to understanding and predicting treatment responses. Traditionally, flow cytometry has been the most common technique used to report cell cycle phases in a population of cells. By fixing the cells and staining for DNA content, flow cytometry can distinguish between cells with one copy of each chromosome (indicating cells in G_{1}/G_{0} ) from cells with two copies of each chromosome (post-replication, so G_{2} and M cells), and those with intermediate DNA content during replication in S phase ( 38 ; 9 ; 22 ; 48 ) . Staining with propidium iodide (PI) indicates a cell’s DNA content, but cannot accurately distinguish between cells in the late- G_{1} and early- S phases, or between cells in the late- S and early- G_{2} phases. 5-bromo-2’-deoxyuridine (BrdU) staining is then used, which identifies cells in the S phase since it is incorporated into newly-replicated DNA. This can be combined with Ki-67 staining, used to distinguish between proliferative and quiescent cells, to report the number of cells in each phase ( 17 ; 29 ) . Staining compounds that do not require the cells to be fixed prior to experiments can also be used, allowing for longitudinal time-series tracking of population-level cell cycle phase progression 44 ; 5 ; 22 . However, these live-cell dyes can invoke more stress on the cell population, and the resulting measurements have a lower resolution than when cells are fixed 44 . Mathematical modelling of tumour growth and the cell cycle is an active field of research, spanning a variety of approaches, including agent-based models, partial differential equations (PDE) and ordinary differential equations (ODE). A review of mathematical modelling of the cell cycle and its impact on treatment strategies is provided by 26 . Several of these 43 ; 18 ; 10 ; 2 ; 7 ; 32 , model cell cycle progression via constant transition rates between the different phases in an ODE model. Implicitly, this assumes that the underlying cell cycle phase length follows an exponential distribution. Experimental data shows that cell populations with initial synchronisation in one cell cycle phase will eventually desynchronise over several complete cycles, giving rise to balanced exponential growth (BEG). This growth regime is characterised by an exponentially growing population count, but with cell cycle phase proportions that settle to a time-independent steady state. Flow cytometry measurements of these proportions can then be used to identify the constant transition rates in ODE models of the cell cycle. Over the past 15 years, Fluorescent Ubiquitination-based Cell Cycle Indicator (FUCCI) has become a widely-used technique to analyse cell cycle progression 56 ; 40 . Rather than staining for DNA content, fluorescent markers are used to indicate accumulation and degradation of cell cycle-regulated proteins. Unlike flow cytometry approaches, FUCCI allows for live tracking of single cells, thus providing higher resolution data such as individual phase durations, lineage tracking and heterogeneity in phase length between cells. An early limitation of FUCCI was the inability to distinguish between S/G_{2}/M phases, which would all fluoresce green, in contrast to the red of G_{1} cells. However, reporting of all four phases is now possible using FUCCI4 3 , which uses replication and mitosis-coupled cell cycle markers to distinguish S and M cells, respectively. Age-structured models of the cell cycle have previously been fitted to both FUCCI imaging and BrdU pulse-labelling data. Weber et al. 50 consider phase lengths following delayed exponential distributions and find that under standard single-pulse BrdU experiments, the means of the phase lengths could be identified, but the variance remained unidentifiable. They propose a re-designed dual-pulse experiment to resolve this issue, highlighting a clear dependence of parameter identifiability on experimental design. The rise of FUCCI and its higher-resolution derivatives has enabled the investigation of parameter identifiability for more complex underlying phase length distributions. Unlike in the work of Weber et al. 50 , we are no longer limited to devising ways to untangle the population-level data generated by flow cytometry methods, and can instead attempt to leverage the single cell data from FUCCI experiments. For example, Billy et al. 4 use FUCCI time-series data to infer phase-transition distributions. These are then embedded in a PDE system and used to compute population growth rates under different experimental conditions. Such approaches focus on parameter estimation from the experimental data, rather than considering structural or practical identifiability of the parameters for the given experimental data. In another pulse-labelling approach, Sherer et al. 42 use an experimental design based on extracting a transient subpopulation to infer age-dependent transition rates between cell cycle phases. Together, this early work demonstrates that such age-structured models can be parametrised using sufficiently rich experimental data, whether that be BrdU labelling, or FUCCI imaging. Most importantly, each of these three prior works uses time-series data for fitting their model parameters. However, mathematical modellers often do not have access to detailed experimental datasets, instead relying on summary population measurements found in the literature, often from a range of cell lines when complete data on the desired cell line is unavailable. As such, when these rich datasets are not available, it remains unclear which model parameters are identifiable from the most commonly available data types, and how the availability of data influences the ability to identify both model parameters and other biologically meaningful quantities. Unlike previous approaches, which demonstrate that richer experimental designs can recover additional structure, we focus on the complementary problem of parameter inference under constrained summary data. In this work, we consider an age-structured population model of the cell cycle, in which each phase has an associated PDE, and transition to the next phase depends on the time spent in the current phase. We assume that each phase length follows a delayed-gamma probability distribution, and derive analytical expressions for key measurable quantities. These include the BEG proportions and coefficients of variation of phase lengths, each of which can be experimentally obtained from either flow cytometry or FUCCI, but are often published without the full time-series dataset from which they are derived. By assuming an increasing number of these quantities are available to us, we consider parameter identifiability of our model in different scenarios. Thus, by requiring a given level of detail from the model, we can evaluate the number of these population summary values required to obtain sufficient data for parameter identifiability. 2 Introducing an age-structured model We split the cell cycle into three compartments, corresponding to cells in G_{1} , S and G_{2}/M . An age-structure variable is introduced to track the length of time spent in each phase. Defining G_{1}(a,t) , S(b,t) and G_{2}(c,t) to be the densities of cells that have been in the G_{1}/S/G_{2} phase for a , b and c hours, respectively, we propose the following system of PDEs to describe their evolution: \frac{\partial G_{1}}{\partial t}+\frac{\partial G_{1}}{\partial a}=-\mu_{1}(a)G_{1}(a,t)+\beta_{4}Q(a,t)-\beta_{5}G_{1}(a,t), (1) \frac{\partial S}{\partial t}+\frac{\partial S}{\partial b}=-\mu_{2}(b)S(b,t), (2) \frac{\partial G_{2}}{\partial t}+\frac{\partial G_{2}}{\partial c}=-\mu_{3}(c)G_{2}(c,t), (3) \frac{\partial Q}{\partial t}=-\beta_{4}Q(a,t)+\beta_{5}G_{1}(a,t), (4) where the total number of cells at time t>0 , P(t) , is given by P(t)=\int_{0}^{\infty}\left(G_{1}(a,t)+Q(a,t)\right)\,da\hskip 2.84544pt+\int_{0}^{\infty}S(b,t)\,db\hskip 2.84544pt+\int_{0}^{\infty}G_{2}(c,t)\,dc, (5) and Q(a,t) is the density of quiescent cells that exited G_{1} with “age” a>0 . Here, \mu_{1}(a),\mu_{2}(b) and \mu_{3}(c) are the rates at which G_{1}/S/G_{2} cells with ages a , b and c progress to the next phase of the cell cycle. We note that there is no a -derivative in the PDE for Q(a,t) , as cell cycle progression is paused during quiescence, and only resumes when cells return to G_{1} . Such cells resume the cell cycle with the same G_{1} age they had when they became quiescent. We close equations ( 1 )-( 4 ) by imposing the following boundary conditions: G_{1}(0,t)=2\int_{0}^{\infty}\mu_{3}(c)G_{2}(c,t)\,dc\hskip 28.45274pt\text{(cell division),} (6) S(0,t)=\int_{0}^{\infty}\mu_{1}(a)G_{1}(a,t)\,da\hskip 28.45274pt\text{(progression from $G_{1}$ to $S$),} (7) G_{2}(0,t)=\int_{0}^{\infty}\mu_{2}(b)S(b,t)\,db\hskip 28.45274pt\text{(progression from $S$ to $G_{2}/M$)}. (8) Many healthy human cells experience contact inhibition, which slows cell cycle progression and the population growth rate as the density of cells increase. However, the work presented here is based on experimental data from cancer cells, which typically lose the contact inhibition that prevents normal cell populations from continuing to grow exponentially 36 . As such, we refrain from imposing any density dependence in the PDE transition rates. In order to capture cell heterogeneity in intermitotic times (the time taken to progress through the cell cycle) of individual cells, we assume that the rates of cell cycle progression and cell division depend on the time spent in the corresponding compartment. The time a cell spends in each cell cycle phase has been shown to differ between cell lines, and can be described by various probability distributions, including gamma, exponential and log-normal distributions ( 55 ; 20 ; 12 ; 50 ; 42 ) . Here we use a delayed gamma distribution as it is analytically tractable. More specifically, we assume that cells in the G_{1} phase move to the S phase with a probability that follows a shifted gamma distribution in a>0 , with further shifted gamma distributions representing the transitions from S to G_{2} , and G_{2} to G_{1} . We include the initial shift to ensure that cells spend at least a fixed, minimum amount of time in each phase, preventing cells jumping from G_{2} to S , for example. Thus, we assume that cells must spend a minimum time T_{1}>0 in the G_{1} phase, after which their progression probability to S follows a Gamma (\alpha_{1},\beta_{1}) distribution. The parameter sets (T_{2},\alpha_{2},\beta_{2} ) and (T_{3},\alpha_{3},\beta_{3}) define the progression rates for S and G_{2} , respectively. We then use the general formula for deriving age-structured transition rates from probability distributions (presented by Stukalin ( 46 ) , Chaffey ( 11 ) and Sherer ( 42 ) ) to obtain the functional forms: \mu_{i}(a)=\begin{cases}\frac{\beta_{i}^{\alpha_{i}}(a-T_{i})^{\alpha_{i}-1}\exp(-\beta_{i}(a-T_{i}))}{\Gamma(\alpha_{i},\beta_{i}(a-T_{i}))},&a>T_{i}\\ 0,&a